← Back to all trendsTrend 04

Future of Healthcare

Genomic medicine, autonomous surgery, and decentralised care are colliding. The clinic of 2035 will look nothing like the hospital of 2015 — and many of its capabilities are already here.

$800B

Global digital health market projected by 2030

10,000+

Genetic diseases targetable by CRISPR therapy

30B

Surgical robotics market size by 2031

01

Genomics & Gene Editing

CRISPR-Cas9 has moved from laboratory curiosity to clinical approval. In 2023, the FDA approved Casgevy — the first CRISPR-based therapy — for sickle cell disease and beta-thalassemia, functionally curing patients with a single infusion. Base editing and prime editing techniques now enable single-letter corrections in the genome with unprecedented precision and minimal off-target effects.

Key Insight

CRISPR therapies are projected to treat over 10,000 genetic diseases — a market worth $15B by 2030.

02

Surgical Robotics & Autonomous Procedures

Intuitive Surgical's da Vinci system has performed over 10 million procedures. The next generation — da Vinci 5, Medtronic Hugo, CMR Surgical Versius — brings haptic feedback, AI-assisted tissue recognition, and semi-autonomous suturing. Fully autonomous surgical bots (STAR, from Johns Hopkins) have already outperformed human surgeons in standardised laparoscopic tasks.

Key Insight

The surgical robotics market will reach $30B by 2031 — growing at 17% CAGR.

03

Decentralised & At-Home Care

Hospital-at-home programmes (Medically Home, Dispatch Health, Amazon Clinic) are expanding from post-surgical recovery to acute care management. FDA-cleared at-home diagnostics now cover strep, COVID, flu, RSV, UTIs, and even basic cardiac rhythm monitoring. The care setting is shifting from institution to individual — driven by cost, access, and patient preference equally.

Key Insight

Hospital-at-home programmes reduce readmission rates by 26% and cut care costs by 30–40% vs inpatient stays.

04

Spatial Computing & AR in Medicine

Apple Vision Pro, Microsoft HoloLens 2, and Medivis Surgical AR are entering the operating theatre. Surgeons overlay CT scan data onto a patient's body during procedures. Medical students rehearse complex surgeries in photo-realistic simulations. In radiology, 3D volumetric rendering on spatial displays is replacing flat PACS screens, enabling faster, more accurate reads.

Key Insight

AR-guided surgery reduces procedure time by 18% and complication rates by 22% in neurosurgical trials.

What's Coming Next

2025

First personalised mRNA cancer vaccines enter Phase 3 trials at scale

2026

AI systems routinely outperform radiologists in 12+ imaging modalities

2028

Continuous glucose + metabolic monitoring becomes mass-market consumer product

2030

CRISPR therapies approved for common polygenic diseases (CAD, T2D)

2035

Brain-computer interfaces (Neuralink, Synchron) restore function in paralysis

The future of health is personal.

FOXO synthesises the frontier of longevity science into programmes you can act on today — not in 2030.